In contrast, CD229 was not found in tumor cells in Hodgkin lymphoma (HL), although it was highly abundant in the tumor microenvironment of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) (Figure 4). Here, LY9 is linked to neoplasm.